140 related articles for article (PubMed ID: 3928818)
21. Intrathecal administration of 5,6-DHT or 5,7-DHT reduces morphine and substance P-antinociceptive activity in the rat.
Rodríguez FD; Rodríguez RE
Neuropeptides; 1989; 13(2):139-46. PubMed ID: 2472573
[TBL] [Abstract][Full Text] [Related]
22. Early postnatal administration of 5,7-DHT: effects on serotonergic neurons and terminals.
Towle AC; Breese GR; Mueller RA; Coyle S; Lauder JM
Brain Res; 1984 Sep; 310(1):67-75. PubMed ID: 6383521
[TBL] [Abstract][Full Text] [Related]
23. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Mueller RA
J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
[TBL] [Abstract][Full Text] [Related]
24. The behavioral effects of depletions of brain serotonin induced by 5,7-dihydroxytryptamine vary with time after administration.
Gately PF; Segal DS; Geyer MA
Behav Neural Biol; 1986 Jan; 45(1):31-42. PubMed ID: 3954713
[TBL] [Abstract][Full Text] [Related]
25. Supersensitivity to L-5-hydroxytryptophan after 5,7-dihydroxytryptamine injections in desmethylimipramine- and nomifensine-pretreated rats: behavioral evidence for postsynaptic supersensitivity.
Ortmann R; Martin S; Waldmeier PC
Psychopharmacology (Berl); 1981; 74(2):109-14. PubMed ID: 6115443
[TBL] [Abstract][Full Text] [Related]
26. Increased behavioural response to 5-methoxy-N,N-dimethyltryptamine but not to RU-24969 after intraventricular 5,7-dihydroxytryptamine administration.
Nisbet AP; Marsden CA
Eur J Pharmacol; 1984 Sep; 104(1-2):177-80. PubMed ID: 6499914
[TBL] [Abstract][Full Text] [Related]
27. 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests.
Eide PK; Hole K; Berge OG; Broch OJ
Brain Res; 1988 Feb; 440(1):42-52. PubMed ID: 2965956
[TBL] [Abstract][Full Text] [Related]
28. Codepletion of serotonin and TRH induces apparent supersensitivity of spinal TRH receptors.
Sharif NA; Burt DR; Towle AC; Mueller RA; Breese GR
Eur J Pharmacol; 1983 Nov; 95(3-4):301-4. PubMed ID: 6317416
[TBL] [Abstract][Full Text] [Related]
29. The effects of hemorrhagic shock on thyrotropin-releasing hormone and its receptors in discrete regions of rat brain.
Ono T; Ogawa N; Mori A
Regul Pept; 1989 May; 25(2):215-22. PubMed ID: 2547227
[TBL] [Abstract][Full Text] [Related]
30. Biochemical evidence for alteration of neostriatal dopaminergic function by 5,7-dihydroxytryptamine.
Liston DR; Franz DN; Gibb JW
J Neurochem; 1982 May; 38(5):1329-35. PubMed ID: 6121011
[TBL] [Abstract][Full Text] [Related]
31. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine.
Stachowiak MK; Stricker EM; Jacoby JH; Zigmond MJ
Biochem Pharmacol; 1986 Apr; 35(8):1241-8. PubMed ID: 2421731
[TBL] [Abstract][Full Text] [Related]
32. Effect of depletion of brain 5-hydroxytryptamine by 5,7-dihydroxytryptamine on ethanol tolerance and dependence in the rat.
Wood JM
Psychopharmacology (Berl); 1980 Jan; 67(1):67-72. PubMed ID: 6768080
[TBL] [Abstract][Full Text] [Related]
33. Effects of TRH, ethanol, and TRH-ethanol combination on activity in rats with altered monoamine content.
Breese GR; Coyle S; Frye GD; Mueller RA
Pharmacol Biochem Behav; 1985 Jun; 22(6):1013-8. PubMed ID: 3927322
[TBL] [Abstract][Full Text] [Related]
34. Facilitation of shock-induced fighting following intraventricular 5,7-dihydroxytryptamine and 6-hydroxydopa.
Kantak KM; Hegstrand LR; Eichelman B
Psychopharmacology (Berl); 1981; 74(2):157-60. PubMed ID: 6791220
[TBL] [Abstract][Full Text] [Related]
35. Intrahypothalamic 5,7-dihydroxytryptamine: temporal analysis of effects on 5-hydroxytryptamine content in brain nuclei and on facilitated lordosis behavior.
Frankfurt M; Renner K; Azmitia E; Luine V
Brain Res; 1985 Aug; 340(1):127-33. PubMed ID: 4027638
[TBL] [Abstract][Full Text] [Related]
36. Some regional anatomical relationships of TRH to 5-HT in rat limbic forebrain.
Sattin A; Kubek MJ; Low WC; Staley CJ; Simon JR
Neurochem Res; 1992 May; 17(5):469-73. PubMed ID: 1382239
[TBL] [Abstract][Full Text] [Related]
37. The guinea pig myoclonic model: behavioral supersensitivity to 5-hydroxytryptophan induced by intracisternal 5,7-dihydroxytryptamine.
Pranzatelli MR; Snodgrass SR
Eur J Pharmacol; 1987 Nov; 143(2):237-42. PubMed ID: 3500866
[TBL] [Abstract][Full Text] [Related]
38. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
[TBL] [Abstract][Full Text] [Related]
39. The effect of intracerebroventricular 5,7-dihydroxytryptamine on morphine analgesia is time-dependent.
Romandini S; Pich EM; Esposito E; Kruszewska AZ; Samanin R
Life Sci; 1986 Mar; 38(10):869-75. PubMed ID: 3951313
[TBL] [Abstract][Full Text] [Related]
40. [Effect of cerebral intraventricular administration of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine on the cyclic secretion of corticosterone in the rat].
Montilla P; Pinilla J; Muñoz MC; Clavero RM
Rev Esp Fisiol; 1984 Sep; 40(3):333-9. PubMed ID: 6522800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
